IE
FBIO icon

Israel Englander’s Fortress Biotech FBIO Stock Holding History

Israel Englander’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,840
Closed -$73K – 3579
2013
Q4 		$73K Sell
1,840
-29,960
-94% -$1.16M ﹤0.01% 3363
2013
Q3 		$3.34M Buy
31,800
+26,180
+466% +$3.21M 0.01% 1356
2013
Q2 		$725K Buy
+5,620
New +$829K ﹤0.01% 2134

Other funds holding FBIO

Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Israel Englander's FBIO Position: Q4 2024 in Review

Israel Englander sold out of Fortress Biotech (FBIO) in Q4 2024, closing a stake of 17,151 shares — an estimated $24.8K sold.

Israel Englander first reported a position in FBIO in Q2 2013 and held it in 30 quarters. The position peaked at $2.02M in Q4 2020. 53 funds tracked by Wall St. Rank hold FBIO as of Q4 2024.

  • Israel Englander reported no remaining Fortress Biotech position as of Q4 2024 after selling out during the quarter.
  • Israel Englander sold 17,151 Fortress Biotech shares in Q4 2024, an estimated $24.8K.
  • Israel Englander first reported a position in Fortress Biotech in Q2 2013 and held it in 30 quarters.
  • Israel Englander's Fortress Biotech position peaked at $2.02M in Q4 2020.
  • 53 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2024.

Based on Millennium Management's 13F filing for Q4 2024, filed 14 Feb 2025.